Cannabis Indica

thcscience_admin
Krishna Chatterjee
CBE FRS FRCP FMedSci
Chatterjee in 2017
Born (1958-04-23) 23 April 1958 (age 66)[1]
Alma materWolfson College, Oxford (BA, BMBCh)[1]
Scientific career
Fields
InstitutionsUniversity of Cambridge
Websitewww.mrl.ims.cam.ac.uk/research/principal-investigators/krishna-chatterjee/

Vengalil Krishna Kumar Chatterjee CBE FRS FRCP FMedSci[2] (born 23 April 1958)[1] is a British endocrinologist. He is a professor of endocrinology in the Department of Medicine at the University of Cambridge[3] and a fellow of Churchill College, Cambridge.[4] He is also the director of the Cambridge Clinical Research Centre, part of the National Institute for Health Research (NIHR).[5]

Education[edit]

Chatterjee was born on 23 April 1958. He was educated at Wolfson College, Oxford, where he was awarded a Bachelor of Arts degree, and a Bachelor of Medicine, Bachelor of Surgery degree in 1982.[1][6]

Research and career[edit]

Chatterjee is distinguished for his discoveries of genetic disorders of thyroid gland formation, regulation of hormone synthesis and hormone action, which have advanced fundamental knowledge of the hypothalamic–pituitary–thyroid axis.[2] He has identified dominant negative inhibition by defective nuclear receptors as a common mechanism in thyroid hormone resistance and peroxisome proliferator-activated receptor gamma (PPARγ)-mediated insulin resistance.[2][7] He has shown how deficiency of human selenocysteine-containing proteins causes a multisystem disease, including disordered thyroid hormone metabolism. He seeks to translate such understanding into better diagnosis and therapy of both rare and common thyroid conditions.[2]

Notable Cambridge scientists with whom Chatterjee has shared paper authorship include Sadaf Farooqi, Stephen O'Rahilly, Antonio Vidal-Puig, and Nick Wareham.

Chatterjee was appointed Commander of the Order of the British Empire (CBE) in the 2023 New Year Honours for services to people with endocrine disorders.[8]

References[edit]

  1. ^ a b c d "Chatterjee, Prof. (Vengalil) Krishna (Kumar)". Who's Who. A & C Black. 2020. doi:10.1093/ww/9780199540884.013.U10709. (Subscription or UK public library membership required.)
  2. ^ a b c d Anon (2017). "Professor Krishna Chatterjee FMedSci FRS". royalsociety.org. London: Royal Society. One or more of the preceding sentences incorporates text from the royalsociety.org website where:

    “All text published under the heading 'Biography' on Fellow profile pages is available under Creative Commons Attribution 4.0 International License.” --"Royal Society Terms, conditions and policies". Archived from the original on 2016-11-11. Retrieved 2016-03-09.{{cite web}}: CS1 maint: bot: original URL status unknown (link)
  3. ^ Krishna Chatterjee publications indexed by the Scopus bibliographic database. (subscription required)
  4. ^ "Professor Krishna Chatterjee". chu.cam.ac.uk. Archived from the original on 2017-08-11.
  5. ^ "Krishna Chatterjee". Wellcome-MRC Institute of Metabolic Science. Retrieved 2022-02-09.
  6. ^ "ORCID". orcid.org. Retrieved 2022-02-09.
  7. ^ O'Rahilly, S.; Barroso, I.; Gurnell, M.; Crowley, V. E. F.; Agostini, M.; Schwabe, J. W.; Soos, M. A.; Maslen, G. LI; Williams, T. D. M.; Lewis, H.; Schafer, A. J.; Chatterjee, V. K. K. (1999). "Dominant negative mutations in human PPARbig gamma associated with severe insulin resistance, diabetes mellitus and hypertension". Nature. 402 (6764): 880–883. Bibcode:1999Natur.402..880B. doi:10.1038/47254. ISSN 0028-0836. PMID 10622252. S2CID 4423555. (subscription required)
  8. ^ "No. 63918". The London Gazette (Supplement). 31 December 2022. p. N9.
source: https://en.wikipedia.org/wiki/Krishna_Chatterjee

Leave a Reply